CD138 is strongly expressed in myeloma but is also shed from the cell surface [31], as well as being sensitive to proteolytic cleavage during cell processing [32], thus we hypothesize that various tissue processing steps can increase this antigenic loss. Here, SDC1 is linked to plasma cell myeloma.